Julien Chuquet
Julien Chuquet
PhD HDR, Associate Professor of Neuroscience, University of ROUEN NORMANDIE, GRHVN Lab, ROUEN
Adresse e-mail validée de
Citée par
Citée par
Local Ca2+ detection and modulation of synaptic release by astrocytes
MA Di Castro, J Chuquet, N Liaudet, K Bhaukaurally, M Santello, ...
Nature neuroscience 14 (10), 1276-1284, 2011
Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
O Touzani, H Boutin, J Chuquet, N Rothwell
Journal of neuroimmunology 100 (1-2), 203-215, 1999
Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex
J Chuquet, P Quilichini, EA Nimchinsky, G Buzsáki
Journal of Neuroscience 30 (45), 15298-15303, 2010
High-resolution in vivo imaging of the neurovascular unit during spreading depression
J Chuquet, L Hollender, EA Nimchinsky
Journal of Neuroscience 27 (15), 4036-4044, 2007
Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor–related protein-mediated transcytosis
K Benchenane, V Berezowski, C Ali, M Fernández-Monreal, ...
Circulation 111 (17), 2241-2249, 2005
Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat
J Chuquet, K Benchenane, J Toutain, ET MacKenzie, S Roussel, ...
Stroke 33 (12), 3019-3025, 2002
Endozepines and their receptors: structure, functions and pathophysiological significance
MC Tonon, H Vaudry, J Chuquet, F Guillebaud, J Fan, O Masmoudi-Kouki, ...
Pharmacology & therapeutics 208, 107386, 2020
Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa
B Galusca, L Jeandel, N Germain, D Alexandre, J Leprince, Y Anouar, ...
The Journal of Clinical Endocrinology & Metabolism 97 (6), 2012-2018, 2012
Rational Design of a Low Molecular Weight, Stable, Potent, and Long-Lasting GPR103 Aza-β3-pseudopeptide Agonist
C Neveu, B Lefranc, O Tasseau, JC Do-Rego, A Bourmaud, P Chan, ...
Journal of Medicinal Chemistry 55 (17), 7516-7524, 2012
Spontaneously hypertensive rats are highly vulnerable to AMPA-induced brain lesions
C Lecrux, O Nicole, L Chazalviel, C Catone, J Chuquet, ET MacKenzie, ...
Stroke 38 (11), 3007-3015, 2007
Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson’s disease
S Bahdoudi, I Ghouili, M Hmiden, JL Do Rego, B Lefranc, J Leprince, ...
Cellular and Molecular Life Sciences 75, 2075-2091, 2018
Molecular basis of agonist docking in a human GPR 103 homology model by site‐directed mutagenesis and structure–activity relationship studies
C Neveu, F Dulin, B Lefranc, L Galas, C Calbrix, R Bureau, S Rault, ...
British Journal of Pharmacology 171 (19), 4425-4439, 2014
Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats
J Chuquet, C Lecrux, D Chatenet, J Leprince, L Chazalviel, S Roussel, ...
Experimental neurology 210 (2), 577-584, 2008
Prolonged deficit of low gamma oscillations in the peri-infarct cortex of mice after stroke
M Hazime, M Alasoadura, R Lamtahri, P Quilichini, J Leprince, D Vaudry, ...
Experimental Neurology 341, 113696, 2021
Detection, characterization and biological activities of [bisphospho-thr3, 9] ODN, an endogenous molecular form of ODN released by astrocytes
K Gach, O Belkacemi, B Lefranc, P Perlikowski, J Masson, ...
Neuroscience 290, 472-484, 2015
Vascular response to spreading depolarization predicts stroke outcome
NF Binder, C Glück, W Middleham, M Alasoadura, N Pranculeviciute, ...
Stroke 53 (4), 1386-1395, 2022
The gliopeptide ODN, a ligand for the benzodiazepine site of GABAA receptors, boosts functional recovery after stroke
R Lamtahri, M Hazime, EK Gowing, RY Nagaraja, J Maucotel, ...
Journal of Neuroscience 41 (33), 7148-7159, 2021
Matching gene expression with hypometabolism after cerebral ischemia in the nonhuman primate
J Chuquet, K Benchenane, G Liot, M Fernández-Monreal, J Toutain, ...
Journal of Cerebral Blood Flow & Metabolism 22 (10), 1165-1169, 2002
Design, synthesis, molecular dynamics simulation, and functional evaluation of a novel series of 26RFa peptide analogues containing a mono-or polyalkyl guanidino arginine …
K Alim, B Lefranc, J Sopkova-de Oliveira Santos, C Dubessy, M Picot, ...
Journal of Medicinal Chemistry 61 (22), 10185-10197, 2018
Cytoprotective and Neurotrophic Effects of Octadecaneuropeptide (ODN) in in vitro and in vivo Models of Neurodegenerative Diseases
O Masmoudi-Kouki, A Namsi, Y Hamdi, S Bahdoudi, I Ghouili, J Chuquet, ...
Frontiers in Endocrinology 11, 566026, 2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20